CoChat

Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study

Open access

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The feasibility of magnetic resonance venography (MRV) for measuring change in thrombus volume with a novel anticoagulation regimen versus standard anticoagulation in patients with symptomatic deep vein thrombosis (DVT) has not been assessed. Our aim was to study the feasibility of MRV to measure change in thrombus volume in patients with acute symptomatic objectively confirmed proximal DVT in an open-label multicenter trial (edoxaban Thrombus Reduction Imaging Study, eTRIS). We randomized patients in a 2:1 allocation ratio to edoxaban 90 mg/day for 10 days followed by 60 mg/day versus parenteral anticoagulation bridging to warfarin for 3 months. The primary efficacy outcome was a surrogate end point of the relative change in MRV-quantified thrombus volume from baseline to Day 14–21. A total of 85 eligible patients from 26 study sites were randomized to edoxaban monotherapy ( n=56) versus parenteral anticoagulation as a ‘bridge’ to warfarin ( n=29). The mean relative change in MRV-quantified thrombus volume from baseline to Day 14–21 was similar in patients treated with edoxaban and parenteral anticoagulation as a ‘bridge’ to warfarin (−50.1% vs −58.9%; 95% confidence interval of treatment difference, −12.7%, 30.2%). However, thrombus extension was observed in eight patients in the edoxaban monotherapy group and in none in the warfarin group. Rates of recurrent venous thromboembolism (3.6% vs 3.6%, p=0.45) and clinically relevant non-major bleeding (5.4% vs 7.1%, p=0.34) were also similar. No major bleeds occurred in either on-treatment group during the study period. In conclusion, MRV can assess change in thrombus volume in patients with acute DVT randomized to two different anticoagulant regimens. ClinicalTrials.gov Identifier: NCT01662908 Investigational New Drug (IND) Application: Edoxaban IND # 63266

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1358863x16645853

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Flow of patients through each stage of the trial. (DVT, deep vein thrombosis; LMWH, low-molecular weight heparin; mITT, modified intention-to-treat.).
Figure 1. Flow of patients through each stage of the trial. (DVT, deep vein thrombosis; LMWH, low-molecular weight heparin; mITT, modified intention-to-treat.).CC BY-NC · PubMed Central
Figure 2. Thrombus volume reduction of 60% from baseline to follow-up as measured by magnetic resonance venography (MRV) in a patient with acute deep vein thrombosis (arrows) randomized to treatment with edoxaban.
Figure 2. Thrombus volume reduction of 60% from baseline to follow-up as measured by magnetic resonance venography (MRV) in a patient with acute deep vein thrombosis (arrows) randomized to treatment with edoxaban.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 1

  1. Mani V, 2015, J Vis Exp, e52761

Cited by

See all 18

Metadata

Authors
Piazza, G., Mani, V., Goldhaber, S. Z., Grosso, M. A., Mercuri, M., Lanz, H. J., Schussler, S., Hsu, C., Chinigo, A., Ritchie, B., Nadar, V., Cannon, K., Pullman, J., Concha, M., Schul, M., Fayad, Z. A., & for the edoxaban Thrombus Reduction Imaging Study (eTRIS) Investigators
Affiliations
  • Brigham and Women's Hospital (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Daiichi Sankyo Pharma Development, Edison, NJ, USA
  • University of Alberta (CA)
  • Lewin and Nadar Cardiology Associates, Camp Hill, PA, USA
  • Wilmington Health, Wilmington, NC, USA
  • St. James Healthcare (US)
  • Intercoastal Medical Group, Sarasota, FL, USA
  • Lafayette Regional Vein and Laser Center, Lafayette, IN, USA
Corresponding author
Piazza, Gregory
Venue
Vascular Medicine
Published
2016-07-07
Volume
21
Issue
4
Pages
361-368
ISSN
  • 1358-863X (ISSN-L)
  • 1477-0377
OpenAlex
W2352106300
Cited by
18
References
15
Citations by year
2025: 1 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 6 · 2017: 2
FWCI
2.67
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Vascular Medicine (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
Keywords
deep vein thrombosis, edoxaban, thrombus volume, magnetic resonance venography, thrombus resolution, parenteral anticoagulation, warfarin, thrombus extension, recurrent venous thromboembolism, bleeding risk
MeSH terms
Administration, Oral, Adult, Aged, Anticoagulants, Blood Coagulation, Drug Therapy, Combination, Feasibility Studies, Female, Heparin, Humans, Male, Middle Aged, Phlebography, Predictive Value of Tests, Pyridines, Thiazoles, Time Factors, United States, Warfarin, Treatment Outcome, Magnetic Resonance Angiography, International Normalized Ratio, Venous Thrombosis, Administration, Intravenous, Factor Xa Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study. https://app.cochat.ai/papers/10.1177/1358863x16645853
The paper
Piazza, G., Mani, V., Goldhaber, S. Z., Grosso, M. A., Mercuri, M., Lanz, H. J., Schussler, S., Hsu, C., Chinigo, A., Ritchie, B., Nadar, V., Cannon, K., Pullman, J., Concha, M., Schul, M., Fayad, Z. A., & for the edoxaban Thrombus Reduction Imaging Study (eTRIS) Investigators. (2016). Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study. Vascular Medicine. https://doi.org/10.1177/1358863x16645853

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.